American Homes 4 Rent Class A vs Merck & Co., Inc. — how do they compare? American Homes 4 Rent Class A trades at $33.27 (market cap $11.97B), while Merck & Co., Inc. trades at $123.56 (market cap $305.12B). The key difference: Merck & Co., Inc. is far larger — about 25.5× American Homes 4 Rent Class A's market cap, and American Homes 4 Rent Class A pays the higher dividend (3.97%). Which is the better fit depends on your goals.
| AMH | MRK | |
|---|---|---|
Market Cap | $11.97B | $305.12B |
Sector | Real Estate | Health |
52-Week High | $36.74 | $129.52 |
52-Week Low | $27.38 | $77.60 |
Enterprise Value | $17.05B | $348.54B |
Dividend Yield | 3.97% | 2.75% |
Signals from Pluang's Aura AI — not financial advice
AMH (American Homes 4 Rent) trades at $33.27, up 1.0% with a bullish technical signal and strong earnings momentum after beating estimates for three consecutive quarters. The company maintains robust fundamentals with 24.48% net income margin and $1.85B revenue in 2025, supported by 95% occupancy rates in the single-family rental market. Recent dividend declaration of $0.33 per share and positive analyst sentiment with 58% buy ratings reinforce strength.
Outlook remains positive given consistent operational performance and strategic focus on Sunbelt and Midwest markets. Key risks include high debt levels at $5.01B and sensitivity to interest rate changes. With consensus price target of $35.68 offering 7.2% upside, the stock presents a compelling opportunity for income and growth investors despite macroeconomic headwinds.
Merck (MRK) trades at $123.54, down 1.22% today, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $135.14. The company reported strong earnings beats in recent quarters, including Q1 2026, and maintains robust profitability with a net income margin of 13.59%. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, signaling strategic growth initiatives amid a competitive pharmaceutical landscape.
The stock presents a favorable risk-reward profile with upside potential driven by earnings momentum and strategic acquisitions, though risks include patent expirations and regulatory pressures. Institutional buying activity and a 67.57% buy rating from analysts underscore confidence, but investors should monitor execution risks and market volatility.
Trailing returns across standard periods
Latest headlines on both assets
American Homes 4 Rent is a real estate investment trust primarily focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's largest geographical markets include Dallas, Texas
Read more on AMH →Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →